Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia

Por Visseren, F. L. J.
Publicado em 2011

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill

Por Lafeber, M., Spiering, W., Visseren, F. L. J., Grobbee, D. E.
Publicado no Curr Hypertens Rep (2016)

Intracellular Infections Enhance Interleukin-6 and Plasminogen Activator Inhibitor 1 Production by Cocultivated Human Adipocytes and THP-1 Monocytes

Por Bouwman, J. J. M., Diepersloot, R. J. A., Visseren, F. L. J.
Publicado em 2009

Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells

Por Faber, D R, Kalkhoven, E, Westerink, J, Bouwman, J J, Monajemi, H M, Visseren, F L J
Publicado em 2012

Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial

Por Vernooij, J W P, Kaasjager, H A H, van der Graaf, Y, Wierdsma, J, Grandjean, H M H, Hovens, M M C, de Wit, G A, Visseren, F L J
Publicado em 2012

Cost-effectiveness of a nurse-led internet-based vascular risk factor management programme: economic evaluation alongside a randomised controlled clinical trial

Por Greving, J P, Kaasjager, H A H, Vernooij, J W P, Hovens, M M C, Wierdsma, J, Grandjean, H M H, van der Graaf, Y, de Wit, G A, Visseren, F L J
Publicado no BMJ Open (2015)